Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of ARS 357.15 trillion. The enterprise value is 390.66 trillion.

Market Cap	357.15T
Enterprise Value	390.66T

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Sep 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.91%
Shares Change (QoQ)	-0.60%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	79.34%
Float	2.48B

Valuation Ratios

The trailing PE ratio is 13.69 and the forward PE ratio is 11.12.

PE Ratio	13.69
Forward PE	11.12
PS Ratio	4.06
PB Ratio	5.02
P/TBV Ratio	17.43
P/FCF Ratio	19.97
P/OCF Ratio	15.27
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.49, with an EV/FCF ratio of 21.84.

EV / Earnings	14.98
EV / Sales	4.21
EV / EBITDA	8.49
EV / EBIT	9.96
EV / FCF	21.84

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.80.

Current Ratio	1.66
Quick Ratio	1.09
Debt / Equity	0.80
Debt / EBITDA	1.30
Debt / FCF	3.17
Interest Coverage	21.34

Financial Efficiency

Return on equity (ROE) is 39.49% and return on invested capital (ROIC) is 19.31%.

Return on Equity (ROE)	39.49%
Return on Assets (ROA)	13.76%
Return on Invested Capital (ROIC)	19.31%
Return on Capital Employed (ROCE)	26.94%
Revenue Per Employee	1.19B
Profits Per Employee	352.51M
Employee Count	75,000
Asset Turnover	0.52
Inventory Turnover	2.24

Taxes

In the past 12 months, Merck & Co. has paid 3.80 trillion in taxes.

Income Tax	3.80T
Effective Tax Rate	12.71%

Stock Price Statistics

The stock price has increased by +36.27% in the last 52 weeks. The beta is 0.32, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	+36.27%
50-Day Moving Average	27,219.00
200-Day Moving Average	22,612.78
Relative Strength Index (RSI)	59.41
Average Volume (20 Days)	5,334

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.09

Income Statement

In the last 12 months, Merck & Co. had revenue of ARS 88.03 trillion and earned 26.09 trillion in profits. Earnings per share was 10,355.40.

Revenue	88.03T
Gross Profit	68.54T
Operating Income	37.26T
Pretax Income	29.90T
Net Income	26.09T
EBITDA	43.20T
EBIT	37.26T
Earnings Per Share (EPS)	10,355.40

Full Income Statement

Balance Sheet

The company has 24.96 trillion in cash and 56.70 trillion in debt, giving a net cash position of -31,740.78 billion.

Cash & Cash Equivalents	24.96T
Total Debt	56.70T
Net Cash	-31,740.78B
Net Cash Per Share	n/a
Equity (Book Value)	71.14T
Book Value Per Share	28,568.74
Working Capital	25.94T

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 23.39 trillion and capital expenditures -5,503.93 billion, giving a free cash flow of 17.88 trillion.

Operating Cash Flow	23.39T
Capital Expenditures	-5,503.93B
Free Cash Flow	17.88T
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 77.85%, with operating and profit margins of 42.33% and 29.63%.

Gross Margin	77.85%
Operating Margin	42.33%
Pretax Margin	33.96%
Profit Margin	29.63%
EBITDA Margin	49.07%
EBIT Margin	42.33%
FCF Margin	20.31%

Dividends & Yields

This stock pays an annual dividend of 493.24, which amounts to a dividend yield of 1.61%.

Dividend Per Share	493.24
Dividend Yield	1.61%
Dividend Growth (YoY)	42.36%
Years of Dividend Growth	2
Payout Ratio	42.60%
Buyback Yield	0.91%
Shareholder Yield	2.52%
Earnings Yield	7.30%
FCF Yield	5.01%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 3.89 and a Piotroski F-Score of 5.

Altman Z-Score	3.89
Piotroski F-Score	5